Di Agostino S - Search Results

1

Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells.

Masciarelli S, Fontemaggi G, Di Agostino S, Donzelli S, Carcarino E, Strano S, Blandino G. Masciarelli S, et al. Among authors: di agostino s. Oncogene. 2014 Mar 20;33(12):1601-8. doi: 10.1038/onc.2013.106. Epub 2013 Apr 15. Oncogene. 2014. PMID: 23584479

2

New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine.

Rago V, Perri A, Di Agostino S. Rago V, et al. Among authors: di agostino s. Biomedicines. 2023 Oct 10;11(10):2743. doi: 10.3390/biomedicines11102743. Biomedicines. 2023. PMID: 37893116 Free PMC article. Review.

3

Novel Insights into the Role of the Antioxidants in Prostate Pathology.

Rago V, Di Agostino S. Rago V, et al. Among authors: di agostino s. Antioxidants (Basel). 2023 Jan 27;12(2):289. doi: 10.3390/antiox12020289. Antioxidants (Basel). 2023. PMID: 36829848 Free PMC article. Review.

4

Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation.

Di Agostino S, Strano S, Emiliozzi V, Zerbini V, Mottolese M, Sacchi A, Blandino G, Piaggio G. Di Agostino S, et al. Cancer Cell. 2006 Sep;10(3):191-202. doi: 10.1016/j.ccr.2006.08.013. Cancer Cell. 2006. PMID: 16959611 Free article.

5

Mutant p53 proteins: between loss and gain of function.

Strano S, Dell'Orso S, Mongiovi AM, Monti O, Lapi E, Di Agostino S, Fontemaggi G, Blandino G. Strano S, et al. Among authors: di agostino s. Head Neck. 2007 May;29(5):488-96. doi: 10.1002/hed.20531. Head Neck. 2007. PMID: 17123310 Review.

6

Mutant p53: an oncogenic transcription factor.

Strano S, Dell'Orso S, Di Agostino S, Fontemaggi G, Sacchi A, Blandino G. Strano S, et al. Among authors: di agostino s. Oncogene. 2007 Apr 2;26(15):2212-9. doi: 10.1038/sj.onc.1210296. Oncogene. 2007. PMID: 17401430 Review.

7

The disruption of the protein complex mutantp53/p73 increases selectively the response of tumor cells to anticancer drugs.

Di Agostino S, Cortese G, Monti O, Dell'Orso S, Sacchi A, Eisenstein M, Citro G, Strano S, Blandino G. Di Agostino S, et al. Cell Cycle. 2008 Nov 1;7(21):3440-7. doi: 10.4161/cc.7.21.6995. Epub 2008 Nov 16. Cell Cycle. 2008. PMID: 18948736

8

PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop.

Lapi E, Di Agostino S, Donzelli S, Gal H, Domany E, Rechavi G, Pandolfi PP, Givol D, Strano S, Lu X, Blandino G. Lapi E, et al. Among authors: di agostino s. Mol Cell. 2008 Dec 26;32(6):803-14. doi: 10.1016/j.molcel.2008.11.019. Mol Cell. 2008. PMID: 19111660 Free article.

9

Promyelocytic leukemia protein is required for gain of function by mutant p53.

Haupt S, di Agostino S, Mizrahi I, Alsheich-Bartok O, Voorhoeve M, Damalas A, Blandino G, Haupt Y. Haupt S, et al. Among authors: di agostino s. Cancer Res. 2009 Jun 1;69(11):4818-26. doi: 10.1158/0008-5472.CAN-08-4010. Cancer Res. 2009. PMID: 19487292

10

Characterization of a new cancer-associated mutant of p53 with a missense mutation (K351N) in the tetramerization domain.

Muscolini M, Montagni E, Caristi S, Nomura T, Kamada R, Di Agostino S, Corazzari M, Piacentini M, Blandino G, Costanzo A, Sakaguchi K, Tuosto L. Muscolini M, et al. Among authors: di agostino s. Cell Cycle. 2009 Oct 15;8(20):3396-405. doi: 10.4161/cc.8.20.9910. Epub 2009 Oct 24. Cell Cycle. 2009. PMID: 19806023

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters